NCT00154297View on ClinicalTrials.gov

Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2008

Conditions
Renal Transplantation
Interventions
DRUG

Everolimus (RAD001)

Trial Locations (1)

Unknown

Novartis, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY